கிஷோர் பாட்டியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கிஷோர் பாட்டியா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கிஷோர் பாட்டியா Today - Breaking & Trending Today

Preclinical Data on New Pancreatic Cancer Drug Shines with over 90% Efficacy

Preclinical Data on New Pancreatic Cancer Drug Shines with over 90% Efficacy
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

United States , Kishor Bhatia , Igor Astsaturov , Marvin Conchetta Greenberg Pancreatic Cancer Institute , Fox Chase Cancer Center , Lantern Pharma , Conchetta Greenberg Pancreatic Cancer , ஒன்றுபட்டது மாநிலங்களில் , கிஷோர் பாட்டியா , நரி துரத்து புற்றுநோய் மையம் , விளக்கு பார்மா ,

દ્વારકાના કિશોરભાઈ ભાટીયાનું કોરોનાથી મૃત્યુ

દ્વારકાના કિશોરભાઈ ભાટીયાનું કોરોનાથી મૃત્યુ
nobat.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nobat.com Daily Mail and Mail on Sunday newspapers.

United Arab Emirates , Dwarkae Mohan Bhatia , Kishor Bhatia , Suresh Upadhyay , Dwarka Mr Kishor , Mohan Bhatia , Switch Mumbai Hospital Corona , ஒன்றுபட்டது அரபு அமீரகங்கள் , கிஷோர் பாட்டியா , சுரேஷ் உபாதியாய் , மோகன் பாட்டியா ,

Lantern Pharma Announces Collaboration with World Leading Brain Cancer Program at Johns Hopkins to Further Develop LP-184 as Therapy for Glioblastoma

Share this article
Share this article
DALLAS, Dec. 17, 2020 /PRNewswire/ Lantern Pharma (Nasdaq: LTRN), a clinical-stage biopharma company using its proprietary RADR
® artificial intelligence ( A.I. ) platform to transform cancer drug development and identify patients who will benefit from its targeted oncology therapeutics, today announced a collaboration and research agreement with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Kennedy Krieger Institute. The collaboration will focus on the further development of Lantern s LP-184 in glioblastoma multiforme (GBM). Based in Baltimore, Johns Hopkins is a leading research center for brain cancers and one of the largest brain tumor treatment and research centers in the world with a focus on treating an extremely large number of patients affected by all types of brain tumors. ....

United States , Marek Ciszewski , John Laterra , Kishor Bhatia , Johns Hopkins , Division Of Neuro , National Cancer Institute , Brain Cancer Program , Drug Administration , Johns Hopkins Sidney Kimmel Comprehensive Cancer Center , Exchange Commission , Oncology At Johns Hopkins School Of Medicine , Lantern Pharma Inc , Securities Exchange , Kennedy Krieger Institute , Lantern Pharma , Kennedy Krieger , Panna Sharma , Johns Hopkins School , Chief Scientific Officer , National Cancer , Securities Act , Securities Exchange Act , United States Food , Risk Factors , ஒன்றுபட்டது மாநிலங்களில் ,